Trial intelligence / Profile preview

Organic nitrate dose-ranging trial for low bone density in postmenopausal women

ACTRN12615001027505Phase 4Completed

Sponsor
The University of Auckland
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of isosorbide mononitrate and nitroglycerin in osteoporosis and low bone mineral density (7 arms), sponsored by The University of Auckland. Primary endpoint: Change in lumbar spine bone mineral density. Started Sep 2016; status: completed.

02

Drugs

isosorbide mononitratenitroglycerin
03

Conditions

osteoporosislow bone mineral density

Beyond the preview

Go deeper on ACTRN12615001027505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615001027505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call